The European Commission decision last week to remove botanicals from the nutrition and health claim process for further review has been welcomed by the botanicals and broader supplements sector.
Late 2011 or the beginning of 2012 is the new date when all non-botanical, European Food Safety Authority generic, article 13.1 opinions will be written into European Union law books, the European Commission’s Basil Mathioudakis told a health claims conference...
The European Food Safety Authority (EFSA) has rejected an article 13.5, gut health claim for a proprietary, two-strain, probiotic product manufactured by Italian firm, Synbiotec.
Scientists from Unilever R&D have modelled the absorption and breakdown of L-theanine in humans, with results that may cast more light on the potential brain benefits of the tea compound.
Unilever has submitted a health claim dossier to the European Food Safety Authority for a skin health food supplement composed of a similar formulation to the market leading Innéov product that had its skin health claim rejected in May this year.
Daily consumption of a lycopene-rich tomato paste reduced reddening of the skin after exposure to UV light, says a new study that supports the skin health potential of lycopene.
Gencor, the Hong Kong based weight loss ingredient supplier, says the European Food Safety Authority (EFSA) has failed to objectively represent the science in rejecting its weight loss claims and subsequent appeal.
The European Food Safety Authority (EFSA) has affirmed five weight loss opinions it handed to Gencor Pacific in April, refuting criticism its health claims panel had discounted certain surrogate trial endpoints.
The protective effects of cranberries toward urinary tract health may also extend to men’s prostates, according to a new study from the Czech Republic – the first of its kind to report such benefits.
An Australian study has found herbal preparations and omega-3s are effective treatments against an array of illnesses including osteoarthritis, heart disease and depression and could save the country more than $220m every year.
The three groups behind the soy protein-cholesterol lowering health claim rejected by the European Food Safety Authority in late July, say EFSA’s tight definition of soy protein denies real world use of the nutrient.
The Malaysian Fisheries Department is backing local universities to mine the nutritive and other potential of local seaweeds to the tune of 8.1m Ringgit (€2.02m).
Biotech start-up Provexis says it will commence two clinical trials in 2011 – one in the area of cardiovascular inflammation, the other in treatment of “hospital superbug” c.difficile.
